The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Kristin Brill named enterprise director of Breast Oncology at SKCC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Breast surgeon Kristin L. Brill has joined the Sidney Kimmel Cancer Center–Jefferson Health as enterprise director of Breast Oncology.

Particular areas of focus for Brill include young women with breast cancer and those at high risk.

Brill joins SKCC from Cooper University Health Care, where she was head of the Division of Breast Surgery and Director of the Janet Knowles Breast Cancer Center at MD Anderson Cancer Center at Cooper and assistant professor of surgery at Cooper Medical School of Rowan University. She also directed the Breast Surgical Oncology Fellowship at Cooper Medical School and was an adjunct assistant professor in the Department of Surgery at MD Anderson Cancer Center.

Table of Contents

YOU MAY BE INTERESTED IN

Podcast

“There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti

In last week’s issue of The Cancer Letter, Jacquelyn Cobb, associate editor, wrote a story about the then-promising legislative package that was passed by the U.S. House of Representatives Jan. 22. At the time, the package was expected to pass in the Senate, provide funding for the federal government through fiscal year 2026, and prevent a government shutdown that looms Jan. 30. 
Capitol Hill

Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched

The U.S. House of Representatives Jan. 22 passed a three-bill minibus package that is expected to be the grand finale of the drama of the fiscal year 2026 appropriations process. The package, which funds the HHS as well as the departments of Defense, Transportation, Housing and Urban Development, Labor, and Education, gives NIH and NCI modest raises over FY25, and nullifies several  aggressive cuts the White House had proposed for NIH.
By Jacquelyn Cobb
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account